Podcast
Play an AI-generated podcast conversation about this lesson
Questions and Answers
Which trial formed the basis for the original 3-hour time window for tPA administration?
Which trial formed the basis for the original 3-hour time window for tPA administration?
- NINDS trial (correct)
- National Institute of Neurological Disorders and Stroke
- European Cooperative Acute Stroke Study (ECASS) I
- Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke
What is the maximum time window for tPA administration in a select group of patients?
What is the maximum time window for tPA administration in a select group of patients?
- 4 hours
- 3 hours
- 4.5 hours (correct)
- 2 hours
What is the absolute risk increase in symptomatic intracerebral hemorrhage (ICH) with IV tPA within 3 hours of symptom onset?
What is the absolute risk increase in symptomatic intracerebral hemorrhage (ICH) with IV tPA within 3 hours of symptom onset?
- 7%
- 8%
- 9%
- 6% (correct)
What is the number needed to treat to achieve good recovery in one patient who would have otherwise had a poor outcome with tPA administration within 3 hours of symptom onset?
What is the number needed to treat to achieve good recovery in one patient who would have otherwise had a poor outcome with tPA administration within 3 hours of symptom onset?
Signup and view all the answers
What did the pooled analysis of the Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke, European Cooperative Acute Stroke Study (ECASS) I and II, and NINDS trials show?
What did the pooled analysis of the Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke, European Cooperative Acute Stroke Study (ECASS) I and II, and NINDS trials show?
Signup and view all the answers
